Malaria, Falciparum
Infectious Diseases
3
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
QT
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
EisaiEfficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria
Heidelberg PharmaMethylene Blue
Q TherapeuticsMMV390048 20mg
Clinical Trials (3)
Total enrollment: 122 patients across 3 trials
NCT04709692EisaiEfficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria
Efficacy of SJ733 in Adults With Uncomplicated Plasmodium Falciparum or Vivax Malaria
Start: Apr 2021Est. completion: Apr 202222 patients
Phase 2Completed
Methylene Blue Against Falciparum Malaria in Burkina Faso
Start: Oct 2016Est. completion: Feb 2017100 patients
Phase 2Completed
MMV390048 Against Early Plasmodium Falciparum Blood Stage Infection in Healthy Participants
Start: Oct 2014Est. completion: Dec 2014
Phase 1Terminated
Related Jobs in Infectious Diseases
Senior Associate Scientist (contract), Upstream Polysaccharide Process Development
VaxCyte
San Carlos, California, United States
6h ago
$56/hr
Senior Associate Scientist (contract), Polysaccharide Analytical Development
VaxCyte
San Carlos, California, United States
6h ago
$56/hr
Director, Program Management
Metaphore Biotechnologies
Somerville, MA USA
10h ago
$179K - $237K/yr
First Line Sales Leader (Medan)
GSK
Indonesia - Sumatera Utara
23h ago
General Worker
GSK
Pakistan - Sindh - Karachi
23h ago
Vaccine Business Manager (Jakarta)
GSK
Indonesia - DKI Jakarta
23h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space